Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.
Han W, Wang L, Li C, Chen J, Zhang W, Wang X, Pang Q, Zhao Y, Sun X, Zhang K, Li G, Li L, Qiao X, Liu M, Wang Y, Deng L, Wang W, Bi N, Zhang T, Deng W, Ni W, Chang X, Zhou Z, Liang J, Feng Q, Wang L, Chen D, Lv J, Zhu S, Han C, Xiao Z.
Han W, et al. Among authors: zhu s.
Ther Adv Med Oncol. 2022 Oct 28;14:17588359221131526. doi: 10.1177/17588359221131526. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 36324733
Free PMC article.